Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Hervé Dombret et al.|The Lancet Oncology|2014Cited by 1.3k
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison Stopeck, Ada Braun, Karim Fizazi et al.|Supportive Care in Cancer|2015Cited by 190
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, H Kantarjian, Michael A. Kelsh et al.|Blood Cancer Journal|2016Cited by 128